Standex International Corp SXI
The biggest changes in the 10-K filed Aug 14, 2026, in management's words
10-K, Item 7This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.
Operating margin
Big change, FY to Jun 30, 2026 vs Jun 30, 2025
“The operating income increase was the result of higher volume, pricing initiatives and product mix, partially offset by growth investments.”
Read it in the 10-K
Net income
Big change, FY to Jun 30, 2026 vs Jun 30, 2025
The MD&A has no sentence that names a cause for this change.
Cash from operations
Big change, FY to Jun 30, 2026 vs Jun 30, 2025
The MD&A has no sentence that names a cause for this change.
Gross margin
Big change, FY to Jun 30, 2026 vs Jun 30, 2025
The MD&A has no sentence that names a cause for this change.
Revenue
Big change, FY to Jun 30, 2026 vs Jun 30, 2025
“Organic sales increased by $43.6 million, or 5.5%, primarily due to increased sales into fast growth markets and contributions from new products.”
Read it in the 10-K
“Organic sales decreased by $53.8 million, or 7.5%, due to general economic softness in Europe and North America in the Electronics segment, the impact of National Institutes of Health (NIH) funding cuts in the Scientific segment and continued softness in North America from delays in new platform rollout in the Engraving & Hydraulics segment.”
Read it in the 10-K
What management said, year by year
The cause given in each 10-K, 2 fiscal years, newest first · MD&A (Item 7)
Each bar is how the line changed that year (from the same 10-K's XBRL). Under it, the sentence in that year's MD&A that names the line, a direction and a cause, word for word. A year with no sentence says so.
Revenue
2 of 2 years explained-
FY 2026 +12.8%
“Organic sales increased by $43.6 million, or 5.5%, primarily due to increased sales into fast growth markets and contributions from new products.”
Read it in the FY 2026 10-K“Organic sales decreased by $53.8 million, or 7.5%, due to general economic softness in Europe and North America in the Electronics segment, the impact of National Institutes of Health (NIH) funding cuts in the Scientific segment and continued softness in North America from delays in new platform rollout in the Engraving & Hydraulics segment.”
Read it in the FY 2026 10-K -
FY 2025 +9.6%
“Organic sales decreased by $53.8 million, or 7.5%, due to general economic softness in Europe and North America in the Electronics segment, the impact of National Institutes of Health (NIH) funding cuts in the Scientific segment and continued softness in North America from delays in new platform rollout in the Engraving segment.”
Read it in the FY 2025 10-K“Organic sales decreased by $37.7 million, or 5.1%, due to transitory headwinds in several of our end markets, primarily due to lower demand in our Electronics, Scientific and Specialty segments, partially offset by project timing in our Engineering Technologies group.”
Read it in the FY 2025 10-K
Gross margin
0 of 2 years explained-
FY 2026 +1.8 pts
The FY 2026 MD&A has no sentence that names a cause for this change.
-
FY 2025 +0.8 pts
The FY 2025 MD&A has no sentence that names a cause for this change.
Operating margin
2 of 2 years explained-
FY 2026 +9.9 pts
“The operating income increase was the result of higher volume, pricing initiatives and product mix, partially offset by growth investments.”
Read it in the FY 2026 10-K -
FY 2025 -2.3 pts
“Operating income increase reflects productivity initiatives and lower freight costs, partially offset by lower volume.”
Read it in the FY 2025 10-K“Operating income increased during the period reflecting productivity actions, offsetting slower demand in North America sales.”
Read it in the FY 2025 10-K
Net income
0 of 2 years explained-
FY 2026 +87.6%
The FY 2026 MD&A has no sentence that names a cause for this change.
-
FY 2025 -23.7%
The FY 2025 MD&A has no sentence that names a cause for this change.
Cash from operations
0 of 2 years explained-
FY 2026 +28.7%
The FY 2026 MD&A has no sentence that names a cause for this change.
-
FY 2025 -24.9%
The FY 2025 MD&A has no sentence that names a cause for this change.
Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K
Sources
The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.
Also
Financials: the numbers year by year.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SXI/export.csv") into a cell.